AAAAAA

   
Results: 1-12 |
Results: 12
Safety of aerosolized INS 365 in patients with mild to moderate cystic fibrosis: Results of a phase I multi-center study
Authors: Noone, PG Hamblett, N Accurso, F Aitken, ML Boyle, M Dovey, M Gibson, R Johnson, C Kellerman, D Konstan, MW Milgram, L Mundahl, J Retsch-Bogort, G Rodman, D Williams-Warren, J Wilmott, RW Zeitlin, P Ramsey, B
Citation: Pg. Noone et al., Safety of aerosolized INS 365 in patients with mild to moderate cystic fibrosis: Results of a phase I multi-center study, PEDIAT PULM, 32(2), 2001, pp. 122-128
Serum and lower respiratory tract drug concentrations after tobramycin inhalation in young children with cystic fibrosis
Authors: Rosenfeld, M Gibson, R McNamara, S Emerson, J McCoy, KS Shell, R Borowitz, D Konstan, MW Retsch-Bogart, G Wilmott, RW Burns, JL Vicini, P
Citation: M. Rosenfeld et al., Serum and lower respiratory tract drug concentrations after tobramycin inhalation in young children with cystic fibrosis, J PEDIAT, 139(4), 2001, pp. 572-577
Effect of Pseudomonas infection on weight loss, lung mechanics, and cytokines in mice
Authors: van Heeckeren, AM Tscheikuna, J Walenga, RW Konstan, MW Davis, PB Erokwu, B Haxhiu, MA Ferkol, TW
Citation: Am. Van Heeckeren et al., Effect of Pseudomonas infection on weight loss, lung mechanics, and cytokines in mice, AM J R CRIT, 161(1), 2000, pp. 271-279
Epidemiologic study of cystic fibrosis: Design and implementation of a prospective, multicenter, observational study of patients with cystic fibrosisin the US and Canada
Authors: Morgan, WJ Butler, SM Johnson, CA Colin, AA FitzSimmons, SC Geller, DE Konstan, MW Light, MJ Rabin, HR Regelmann, WE Schidlow, DV Stokes, DC Wohl, MEB Kaplowitz, H Wyatt, MM Stryker, S
Citation: Wj. Morgan et al., Epidemiologic study of cystic fibrosis: Design and implementation of a prospective, multicenter, observational study of patients with cystic fibrosisin the US and Canada, PEDIAT PULM, 28(4), 1999, pp. 231-241
Patterns of medical practice in cystic fibrosis: Part I. Evaluation and monitoring of health status of patients
Authors: Konstan, MW Butler, SM Schidlow, DV Morgan, WJ Julius, JR Johnson, CA
Citation: Mw. Konstan et al., Patterns of medical practice in cystic fibrosis: Part I. Evaluation and monitoring of health status of patients, PEDIAT PULM, 28(4), 1999, pp. 242-247
Patterns of medical practice in cystic fibrosis: Part II. Use of therapies
Authors: Konstan, MW Butler, SM Schidlow, DV Morgan, WJ Julius, JR Johnson, CA
Citation: Mw. Konstan et al., Patterns of medical practice in cystic fibrosis: Part II. Use of therapies, PEDIAT PULM, 28(4), 1999, pp. 248-254
IL-10 attenuates excessive inflammation in chronic Pseudomonas infection in mice
Authors: Chmiel, JF Konstan, MW Knesebeck, JE Hilliard, JB Bonfield, TL Dawson, DV Berger, M
Citation: Jf. Chmiel et al., IL-10 attenuates excessive inflammation in chronic Pseudomonas infection in mice, AM J R CRIT, 160(6), 1999, pp. 2040-2047
Altered respiratory epithelial cell cytokine production in cystic fibrosis
Authors: Bonfield, TL Konstan, MW Berger, M
Citation: Tl. Bonfield et al., Altered respiratory epithelial cell cytokine production in cystic fibrosis, J ALLERG CL, 104(1), 1999, pp. 72-78
Pitfall in the use of genotype analysis as the sole diagnostic criterion for cystic fibrosis
Authors: Chmiel, JF Drumm, ML Konstan, MW Ferkol, TW Kercsmar, CM
Citation: Jf. Chmiel et al., Pitfall in the use of genotype analysis as the sole diagnostic criterion for cystic fibrosis, PEDIATRICS, 103(4), 1999, pp. 823-826
Estimating effectiveness in an observational study: A case study of dornase alfa in cystic fibrosis
Authors: Johnson, CA Butler, SM Konstan, MW Breen, TJ Morgan, WJ
Citation: Ca. Johnson et al., Estimating effectiveness in an observational study: A case study of dornase alfa in cystic fibrosis, J PEDIAT, 134(6), 1999, pp. 734-739
The use of anti-inflammatory medications in cystic fibrosis - Trends and physician attitudes
Authors: Oermann, CM Sockrider, MM Konstan, MW
Citation: Cm. Oermann et al., The use of anti-inflammatory medications in cystic fibrosis - Trends and physician attitudes, CHEST, 115(4), 1999, pp. 1053-1058
Immunopathogenesis of cystic fibrosis lung disease
Authors: Berger, M Konstan, MW
Citation: M. Berger et Mw. Konstan, Immunopathogenesis of cystic fibrosis lung disease, CYSTIC FIBROSIS IN ADULTS, 1999, pp. 115-143
Risultati: 1-12 |